39 related articles for article (PubMed ID: 22967101)
1. SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study.
Fransvea E; Trerotoli P; Sacco R; Bernabucci V; Milella M; Napoli N; Mazzocca A; Renna E; Quaranta M; Angarano G; Villa E; Antonaci S; Giannelli G
J Viral Hepat; 2012 Oct; 19(10):704-10. PubMed ID: 22967101
[TBL] [Abstract][Full Text] [Related]
2. Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen-associated (SCCA) variants' serum levels in anti-HCV positive cirrhotic patients.
Giannini EG; Basso M; Bazzica M; Contini P; Marenco S; Savarino V; Picciotto A
J Viral Hepat; 2010 Aug; 17(8):563-8. PubMed ID: 19840364
[TBL] [Abstract][Full Text] [Related]
3. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
[TBL] [Abstract][Full Text] [Related]
4. Viral decline over 48h and HCV amino acid mutations are related to efficacy of PEG-IFN/ribavirin.
Miyasaka A; Kumagai I; Abe K; Suzuki K
Hepatogastroenterology; 2012 May; 59(115):794-9. PubMed ID: 22020909
[TBL] [Abstract][Full Text] [Related]
5. Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients.
Giannini EG; Basso M; Savarino V; Picciotto A
Aliment Pharmacol Ther; 2010 Feb; 31(4):502-8. PubMed ID: 19925499
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy.
Köberle V; Waidmann O; Kronenberger B; Andrei A; Susser S; Füller C; Perner D; Zeuzem S; Sarrazin C; Piiper A
J Viral Hepat; 2013 Aug; 20(8):530-5. PubMed ID: 23808991
[TBL] [Abstract][Full Text] [Related]
7. Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.
Biasiolo A; Tono N; Zaninotto M; Merkel C; Fassina G; Plebani M; Gatta A; Pontisso P
J Med Virol; 2013 Jun; 85(6):1005-8. PubMed ID: 23588726
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC).
Pozzan C; Cardin R; Piciocchi M; Cazzagon N; Maddalo G; Vanin V; Giacomin A; Pontisso P; Cillo U; Farinati F
J Gastroenterol Hepatol; 2014 Aug; 29(8):1637-44. PubMed ID: 24635038
[TBL] [Abstract][Full Text] [Related]
9. HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.
Martini A; Fattovich G; Guido M; Bugianesi E; Biasiolo A; Ieluzzi D; Gallotta A; Fassina G; Merkel C; Gatta A; Negro F; Pontisso P
J Viral Hepat; 2015 Oct; 22(10):800-8. PubMed ID: 25611978
[TBL] [Abstract][Full Text] [Related]
10. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis.
Zuin J; Veggiani G; Pengo P; Gallotta A; Biasiolo A; Tono N; Gatta A; Pontisso P; Toth R; Cerin D; Frecer V; Meo S; Gion M; Fassina G; Beneduce L
Clin Chem Lab Med; 2010 Feb; 48(2):217-23. PubMed ID: 20001440
[TBL] [Abstract][Full Text] [Related]
11. Squamous cell carcinoma antigen production in nasal inverted papilloma.
Suzuki M; Deng Z; Hasegawa M; Uehara T; Kiyuna A; Maeda H
Am J Rhinol Allergy; 2012; 26(5):365-70. PubMed ID: 23168150
[TBL] [Abstract][Full Text] [Related]
12. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.
Guarino M; Di Costanzo GG; Gallotta A; Tortora R; Paneghetti L; Auriemma F; Tuccillo C; Fassina G; Caporaso N; Morisco F
Scand J Clin Lab Invest; 2017 Oct; 77(6):448-453. PubMed ID: 28609160
[TBL] [Abstract][Full Text] [Related]
13. Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis.
Cagnin M; Biasiolo A; Martini A; Ruvoletto M; Quarta S; Fasolato S; Angeli P; Fassina G; Pontisso P
Sci Rep; 2019 Dec; 9(1):20126. PubMed ID: 31882893
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients.
Gallotta A; Paneghetti L; Mrázová V; Bednárová A; Kružlicová D; Frecer V; Miertus S; Biasiolo A; Martini A; Pontisso P; Fassina G
Int J Biol Markers; 2018 May; 33(2):231-236. PubMed ID: 29712495
[TBL] [Abstract][Full Text] [Related]
15. Serum SCCA levels in patients suffering cancers or other diseases.
Yang D; Wang J; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():165-175. PubMed ID: 30905447
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors determining the outcome of treatment in chronic hepatitis C.
Hadziyannis SJ
Acta Gastroenterol Belg; 2000; 63(2):207-9. PubMed ID: 10925467
[TBL] [Abstract][Full Text] [Related]
17. Serum Squamous Cell Carcinoma Antigen in Psoriasis: A Potential Quantitative Biomarker for Disease Severity.
Sun Z; Shi X; Wang Y; Zhao Y
Dermatology; 2018; 234(3-4):120-126. PubMed ID: 29870999
[TBL] [Abstract][Full Text] [Related]
18. Immunoassay for quantifying squamous cell carcinoma antigen in serum.
Erickson JA; Lu J; Smith JJ; Bornhorst JA; Grenache DG; Ashwood ER
Clin Chem; 2010 Sep; 56(9):1496-9. PubMed ID: 20601447
[TBL] [Abstract][Full Text] [Related]
19. Serum squamous cell carcinoma antigen: a potential marker for benign vulval disease?
Abukhalil I; Redman C; Strange R
Clin Exp Obstet Gynecol; 1995; 22(4):265-7. PubMed ID: 8777777
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of the Squamous Cell Carcinoma Antigen (SCCA) Which Has a Significant Difference in Values between CLIA and FEIA--Case Report of Extra Glycosylation in SCCA].
Maruyama K; Aoki Y; Yamanaka M; Ono M; Hotta T; Kang D
Rinsho Byori; 2016 Mar; 64(3):265-9. PubMed ID: 27363218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
